There’s still little evidence of the big things that have long been expected for the JSE’s bombed-out small-cap counters so far in 2019. With the overall market — courtesy of an early resource sector rally and sprightlier performance from market heavyweights like Naspers, British American Tobacco, Richemont and AB InBev — looking firmer in the first quarter, there was a more than reasonable expectation from wide-eyed punters that small-cap counters might catch this swelling wave of improved sentiment. Not quite. Risk aversion still seems prevalent in 2019, which probably means further outflows from smaller-cap counters — perceived as higher risk — to the relative safety of recovering blue-chip counters. Some of the most popular small-cap counters have actually got cheaper — and, in some instances, a whole lot cheaper. There are more than a few notable mid-cap fizzles — including PSG-owned agribusiness Zeder, health-care group Ascendis (now a small cap by definition), Blue Label Tele...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now